In an ordinal analysis of the modified Rankin scale score at 90 days, patients in the tenecteplase group had a median score of 2 (interquartile range, 0 to 3), which indicated significantly better ...

The session focused on the evolution of stroke care, particularly ischemic strokes, which make up 87% of all strokes. It ...

Analysis of categorized scores on the modified Rankin scale confirmed the lack of benefit: the odds ratio for trichotomization into modified Rankin scale scores of 0 to 1 versus 2 to 3 versus 4 to ...

Researchers found that the percentage of patients achieving a score of 0 or 1 on the modified Rankin scale at 90 days was 40.3 and 26.3% in the alteplase and standard medical treatment groups ...

Delirium affected 44% of critically ill patients in an Ohio medical center who were hospitalized after a recent stroke, ...

Modified Rankin Scale (mRS): This assesses a person’s level of disability after a stroke. It evaluates six different levels of disability, which include: 0: There are no symptoms.

The primary endpoint was a predefined clinical outcome based on the proportion of patients who achieved a modified Rankin Scale score of 0-1 at 90 to 120 days, as assessed by the Rankin Focused ...

Consequently, the modified Rankin Scale (mRS) has been commonly used to evaluate outcome and even success of neurosurgical treatment. However, the scale was originally created to monitor the recovery ...

Stroke survivors were 44% more likely to have an excellent outcome (modified Rankin score 0-1) after 90 days if they received the tenecteplase injection and standard care after clot removal ...

Results. Compared to healthy subjects, patients with ischemic stroke, especially those with a modified Rankin scale ≥ 4, had impaired GMA in both fasting and postprandial states.